Since the outbreak of COVID-19 in China in December 2019, a pandemic has rapidly developed on a scale that has overwhelmed health services us polo assn mens sweaters in a number of countries.COVID-19 has the potential to lead to severe hypoxia; this is usually the cause of death if it occurs.In a substantial number of patients, adequate arterial oxygenation cannot be achieved with supplementary oxygen therapy alone.To date, there has been no clear guideline endorsement of ward-based non-invasive pressure support (NIPS) for severely hypoxic patients who are deemed unlikely to benefit from invasive ventilation.We established a ward-based NIPS service for COVID-19 PCR-positive patients, with severe hypoxia, and in whom escalation to critical care for invasive ventilation was not deemed appropriate.
A retrospective analysis of survival in these patients was undertaken.Twenty-eight patients were included.Ward-based NIPS for severe hypoxia was associated with a 50% survival in this cohort.This compares favourably with Intensive Care National Audit and Research Centre survival data following invasive ventilation in a less frail, less comorbid and younger population.These results suggest luau thank you cards that ward-based NIPS should be considered as a treatment option in an integrated escalation strategy in all units managing respiratory failure secondary to COVID-19.